Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
62 participants
INTERVENTIONAL
2020-01-27
2020-04-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study is designed as non-blinding randomized control trial. Subject who adhere with less than 85 percent fasting (14 out of 16) will be dropped out from this study. Total sample in this study is 62 students which are 31 students for each group.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Intermittent Fasting Among Adult Population
NCT05521945
Intermittent Fasting on Body Fat and Quality of Life
NCT06307275
Effect Of Intermittent Fasting To Metabolic And Oxidative Stress Marker
NCT04319133
Effect of Intermittent Fasting (Month of Ramadan) on Health
NCT05571891
Short Term Intermittent Fasting and Insulin Resistance
NCT02420054
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Subjects will be distributed to each group by using randomization block of four.
This study will use 8 forms consist of; informed consent, subject selection form, re-anthropometric measurement form, questionnaire, semi quantitative food frequency questionnaire (SQ-FFQ), international physical activity questionnaire (IPAQ), food record book, and control and evaluation form. While the tolls are consist of food photograph book (to help in filling the food record book), body height scale, and bio-electrical impedance analysis (BIA) Seca medical body composition analyzer (mBCA) 515/514 (to measure body composition).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
Subject will ask to do 5:2 intermittent fasting (2 non-consecutive days a week) within 8 weeks
Fasting
Doing fasting 2 days a week within 8 weeks
Control
Subject will prohibited from doing fasting or intake restriction within 8 weeks
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fasting
Doing fasting 2 days a week within 8 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* do not have experience on amputation
* willingness to participate in the whole study by signing informed consent
Exclusion Criteria
* in a certain diet at the moment
* consuming lipid-lowering drug at the moment
* doing regular fasting (2 days a week) for 2 months before the study begin
* suffer from chronic illness (confirmed by disease history form
* using electronic implants, for example pacemaker or pane
* using prostheses (artificial body part)
18 Years
25 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Indonesia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hadiyati Fudla
Master Student at Faculty of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hadiyati HF Fudla
Role: PRINCIPAL_INVESTIGATOR
Indonesia University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Indonesia University
Depok, West Java, Indonesia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Ninik NM Mudjihartini
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KET/1354/UN2.F1/ETIK
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.